azomycin has been researched along with Hemolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abgrall, A; Augé, C; Blesson, S; Filali-Ansary, A; Mordt, OV; Pellissier, F; Sanderink, GJ; Souchaud, M | 1 |
| Barbosa, LR; Caetano, W; Hsu, HW; Itri, R; Pessoa, A; Rangel-Yagui, CO; Tavares, LC | 1 |
2 other study(ies) available for azomycin and Hemolysis
| Article | Year |
|---|---|
A DBS method for quantitation of the new oral trypanocidal drug fexinidazole and its active metabolites.
Topics: Administration, Oral; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Dried Blood Spot Testing; Hematocrit; Hemolysis; Humans; Linear Models; Nitroimidazoles; Quality Control; Tandem Mass Spectrometry; Temperature; Time Factors; Trypanocidal Agents | 2016 |
Novel potential drug against T. cruzi and its interaction with surfactant micelles.
Topics: Animals; Chagas Disease; Erythrocytes; Hemolysis; Hydrazones; Micelles; Nitrofurans; Nitroimidazoles; Scattering, Small Angle; Sheep; Solubility; Surface-Active Agents; Trypanocidal Agents; Trypanosoma cruzi; X-Ray Diffraction | 2007 |